China Dog Bite Vaccine For Rabies Prevention After Dog Exposure Manufacturer, Supplier, Factory

As a top China factory supplier, AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. launches premium Dog Bite Vaccine For Rabies Prevention After Dog Exposure, the freeze-dried Vero cell rabies injection built on domestic aG virus strain with verified 100% antibody seroconversion rate within 14 days post full inoculation. This WHO-aligned post-exposure vaccine eliminates preservatives and bovine serum residues, fits all dog bite & scratch exposure tiers II & III, supports bulk cross-border procurement for global CDCs, pet clinics and emergency medical facilities with stable annual output of 22 million doses and complete cold-chain export packaging to Africa, Southeast Asia and Central Asia.

Product Core Purpose

This rabies biological preparation targets emergency prophylaxis after dog contact injuries, solving the near-100% fatality risk of untreated rabies virus infection caused by dog bites or scratches. It activates human body’s specific neutralizing antibody production to block rabies virus replication inside the nervous system, splitting applicable exposure grades per WHO global rabies management rules.

● Grade II Dog Exposure: Non-bleeding superficial scratches, minor skin nips without broken dermis; single vaccine 5-dose schedule without immunoglobulin combination

● Grade III Dog Exposure: Deep bleeding dog bites, broken skin contact with dog saliva, mucous membrane exposure to canine secretions; combine Dog Bite Vaccine For Rabies Prevention After Dog Exposure with rabies immunoglobulin at 20IU/kg body weight for dual protection

All vaccine batches pass strict internal potency testing, meeting the minimum 0.5 IU/ml neutralizing antibody threshold set by WHO rabies prevention guidelines to eliminate post-bite infection risks thoroughly.

Exclusive Technical Advantages

Distinct from generic imported and domestic rabies shots, this post-dog-exposure vaccine carries two core technical breakthroughs from AIM Honor’s 20+ years viral vaccine R&D experience, creating unmatched safety and immune efficiency benchmarks.

1. Mature Domestic aG Virus Strain Culture: The proprietary aG rabies fixed strain selected for Dog Bite Vaccine For Rabies Prevention has undergone decades of clinical verification in Chinese population, generating more balanced humoral and cellular immune response compared to foreign PV strains

2. Zero Preservative & Bovine Serum Formula: The full production flow avoids adding antibiotic residues, formaldehyde excess and animal serum contaminants, drastically cutting mild allergic reaction incidence to only 10%-20% (limited transient injection redness, low-grade fever that resolves within 48 hours naturally)

3. Dual Production Line Layout: Conventional Vero cell freeze-dried version for cost-effective mass procurement; innovative serum-free Vero cell iteration product under marketing review, completely removing animal-derived raw material risks in cell culture and virus amplification links

As the world’s second largest rabies vaccine production base, AIM Honor’s factory deploys automated closed fermentation workshops to guarantee consistent antigen titer across every batch of this dog bite prevention vaccine.

Full Technical Specification Table

The specification table covers all core procurement indicators for hospital purchasing departments, cross-border medical distributors and national disease control bureaus, enabling direct batch comparison for bulk tender projects of Dog Bite Vaccine For Rabies Prevention.

Global Application Fields

This dog bite post-exposure rabies vaccine serves diversified medical and public health scenarios worldwide, matching procurement demands of different institutional clients with flexible order volume support.

● Emergency Medical Institutions: Community emergency rooms, general hospital trauma departments, infectious disease clinics for immediate vaccination after dog bite/scratch injuries; widely stocked in county-level CDCs covering all 31 Chinese provinces, with export channels extending to African rabies high-incidence belt nations

● Pet Industry Facilities: Large pet hospitals, canine breeding bases, pet grooming shops to provide occupational exposure protection for staff frequently contacting dogs

● National Public Health Campaigns: Bulk tender supply for government rabies elimination projects in Southeast Asia, Central Asia and Sub-Saharan Africa; factory supports customized export packaging with complete cold-chain labeling per international shipping standards

● Travel Health Clinics: Immunization supply for travelers heading to regions with high canine rabies prevalence as pre-exposure preventive backup plus post-bite emergency treatment solution

Quality Certification System

Every batch of Dog Bite Vaccine For Rabies Prevention undergoes multi-layered official quality inspection before delivery, backed by complete legal production credentials from Chinese national drug supervision authorities.

1. Core Manufacturing Qualifications: AIM Honor holds valid Drug Production License and Business License issued by Zhejiang Provincial Medical Products Administration, all production lines fully passed national GMP certification with independent quality control lab equipped with viral titer detection equipment

2. Factory Standardization Control: The Ningbo production base operates closed sterile bioreactor workshops, automated filling and lyophilization assembly lines to eliminate manual contamination risks during vaccine manufacturing

3. Export Compliance Support: The company provides full batch release reports, COO (Certificate of Origin), health certificates and cold-chain transport qualification documents for cross-border customs clearance; currently advancing PIC/S factory inspection preparation to meet stricter international pharmaceutical audit standards

4. Safety Monitoring Mechanism: Global post-market adverse reaction tracking system records all injection feedback, continuously optimizing vaccine formula based on real-world clinical data from over 100 million cumulative doses supplied globally

Target Applicable Crowds

All people exposed to dog bites, dog scratches or canine saliva mucosal contact can receive inoculation with this freeze-dried Vero cell rabies vaccine, with no absolute contraindication for exposed individuals facing fatal rabies risk.

1. General Exposed Population: Children, adults, seniors suffering from any grade dog-related skin injury without prior complete rabies vaccination

2. Special Vulnerable Groups: Pregnant women, lactating mothers, patients with mild chronic diseases; rabies fatality rate reaches nearly 100% without timely immunization, so vaccination priority is recommended regardless of pregnancy or mild underlying illness

3. High-Occupation-Risk Staff: Dog breeders, veterinary practitioners, animal rescue volunteers, CDC rabies laboratory workers with frequent canine contact exposure possibility

4. Travelers to High-Risk Zones: Individuals planning long-term stays in Africa, South Asia and rural Southeast areas with uncontrolled stray dog populations; can receive pre-exposure shots with this vaccine for advance protection

Only patients with confirmed severe hypersensitivity to vaccine excipients (Vero cell protein, aluminum adjuvant) are prohibited from inoculating Dog Bite Vaccine For Rabies Prevention; mild allergic constitution individuals require 30-minute on-site observation after each injection dose.

Why Choose Our Factory Supply

Compared with small-scale biotech traders and secondary vaccine distributors, direct factory cooperation with AIM Honor brings unique procurement advantages for buyers of dog bite post-exposure rabies vaccine.

● Large-Scale Stable Output: Annual vaccine production capacity hits 22 million doses, capable of fulfilling large government tender bulk orders without stock shortage risks year-round

● Direct Factory Ex-Factory Pricing: Eliminate intermediate markup links for cross-border medical distributors, flexible MOQ negotiation for small trial orders and national level large-volume procurement contracts

● Global Cold Chain Logistics Guidance: Professional foreign trade team provides standardized 2–8℃ refrigerated packaging scheme, complete temperature monitoring records for ocean and air freight shipments

● Professional Technical After-Sales Team: Multilingual vaccine technical support staff supply injection schedule guides, adverse reaction handling manuals and customs document templates for overseas clients

● Brand Global Trust Record: AIM Vaccine (Stock Code:06660.HK) is China’s largest private full-industry-chain vaccine group, recognized as the world’s second-largest rabies vaccine manufacturer with product sales to more than 20 countries worldwide

FAQ Customer Inquiry Guide

Q1: Is this vaccine effective if I get injected more than 24 hours after dog bite exposure?

A1: Yes, Dog Bite Vaccine For Rabies Prevention After Dog Exposure still delivers full protective effect as long as rabies clinical symptoms have not appeared. Delayed vaccination will not invalidate protection; you must complete the full 5-dose or simplified 4-dose schedule immediately. For Grade III severe dog bite exposure, simultaneous rabies immunoglobulin injection is mandatory regardless of time delay to block latent virus invasion.

Q2: What mild side effects may occur after injection, and how to manage them?

A2: Transient local swelling, injection site pain or low-grade fever within 24–72 hours are common, occurring in 10%-20% of vaccine recipients. These symptoms automatically subside within 1–2 days without special treatment. Seek emergency medical service instantly if severe whole-body rash, anaphylactic shock or sustained high fever above 39℃ appears after inoculation; all vaccination sites must reserve epinephrine for emergency rescue as per national vaccine management rules.

Q3: Can pregnant women or breastfeeding mothers receive this dog bite rabies vaccine?

A3: Completely safe for pregnant and lactating populations. The inactivated Vero cell vaccine contains live attenuated virus zero risk, no verified adverse impacts on fetus or breastfed infants. Rabies infection carries a 100% mortality rate, so exposed pregnant/breastfeeding women must prioritize completing the full immunization course without delay.

Q4: What delivery cycle can I expect after bulk order payment?

A4: After receiving client’s formal payment deposit, our factory arranges vaccine production batch locking within 2 working days. Standard delivery lead time is 30 working days, adjustable based on order quantity and export port schedule. For urgent emergency public health orders from rabies outbreak regions, we can activate priority production lines to shorten shipment period upon mutual written confirmation.

Q5: What storage rules should overseas distributors follow during transit and warehouse stocking?

A5: Dog Bite Vaccine For Rabies Prevention requires constant 2–8℃ refrigeration for all storage and transportation phases; freezing will permanently damage vaccine antigen activity and render the product ineffective. All export packages include built-in temperature loggers to record full cold-chain transit data for customs and client inspection; finished vaccines cannot be exposed to direct sunlight for long periods.

Final Purchase Call

As an officially licensed rabies vaccine factory with decades of manufacturing experience, AIM Honor (Ningbo) Biopharmaceutical Co., Ltd. offers stable, safe and cost-effective Dog Bite Vaccine For Rabies Prevention After Dog Exposure for global medical institutions, national disease control bureaus and cross-border pharmaceutical distributors. If you need bulk quotation, free batch test sample consultation, export document support or customized packaging solutions, send your detailed procurement demand to our international business mailbox international@aimbio.com, our professional vaccine sales team will reply with competitive factory price within 24 working hours and provide full technical data sheets and qualification attachments for your tender and import clearance work.